<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>FDA regulatory affairs</title>
  </titleInfo>
  <name type="personal">
    <namePart>Mantus, David</namePart>
    <role>
      <roleTerm type="text">editor of compilation.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Pisano, Douglas J.</namePart>
    <role>
      <roleTerm type="text">editor of compilation.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">flu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">UK</placeTerm>
    </place>
    <publisher> CRC Press/Taylor &amp; Francis Group</publisher>
    <dateIssued>2024</dateIssued>
    <dateIssued encoding="marc">2014</dateIssued>
    <edition>Third edition.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xii, 387 pages ; 24 cm</extent>
  </physicalDescription>
  <tableOfContents>Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the GxPs for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake, Esq. -- The practice of regulatory affairs / David S. Mantus -- FDA advisory Committees / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner, Esq.</tableOfContents>
  <note type="statement of responsibility">edited by David Mantus, Douglas J. Pisano.</note>
  <note>Includes bibliographical references and index.</note>
  <note>PHR phr PHAR</note>
  <note>TRIM</note>
  <subject authority="mesh">
    <name type="corporate">
      <namePart>United States.</namePart>
      <namePart>Food and Drug Administration.</namePart>
    </name>
  </subject>
  <subject authority="mesh">
    <topic>Drug Approval</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>United States Government Agencies</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Biological Products</topic>
    <topic>standards</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Equipment and Supplies</topic>
    <topic>standards</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Government Regulation</topic>
    <geographic>United States</geographic>
  </subject>
  <classification authority="ddc" edition="23">61519 F287</classification>
  <identifier type="isbn">978104116396</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">DNLM/DLC</recordContentSource>
    <recordCreationDate encoding="marc">260728</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260728100835.0</recordChangeDate>
    <recordIdentifier>57914</recordIdentifier>
  </recordInfo>
</mods>
